...
首页> 外文期刊>CERAMICS INTERNATIONAL >Synthesis, characterization and in vitro bioactivity of mesoporous copper silicate bioactive glasses
【24h】

Synthesis, characterization and in vitro bioactivity of mesoporous copper silicate bioactive glasses

机译:介孔铜硅酸盐生物活性玻璃的合成,表征和体外生物活性

获取原文
获取原文并翻译 | 示例
           

摘要

In this study, 68SiO(2)-23CaO-4P(2)O(5)-CuO bioglasses with and without surfactant (nonionic block copolymer, E020P070E020 P123) for producing multifunctional scaffold were synthesized by sol-gel method. The resulting dried sol underwent an evaporation-induced self-assembly (EISA) process at 40 degrees C. TG-DTA (thermogravimetric-differential thermal analysis) was completed to obtain the optimized temperature for calcination of the prepared powder. The dried gel was calcined at 650 degrees C for 2 h to obtain the final bioglasses. Then, the composition and phase structure, morphology, surface area and mesoporous structure were evaluated by Fourier transform infrared spectroscopy (FTIR), X-ray diffraction (XRD), scanning electron microscopy (SEM), transmission electron microscopy (TEM), Brunauer-Emmett-Teller (BET) analyses. In addition, the biological behavior (bioactivity, biocompatibility and antibacterial properties) of the powder was examined for their applicability in medical science. The results demonstrated that the synthesized bioglass powder formed mesoporous structure with nano sized morphology and high surface area, and also suitable biological characteristics. The P123 (the nonionic block copolymer E020P070E020) surfactant was responsible for improving homogeneous mesoporous structures and biological characteristics for the template bioglass. In addition, the use of copper in the glass structure did not inhibit its anti-bacterial properties and resulted in a low risk toxic bioglass. Finally, this synthesized bioactive glass could have the potential capability for bone defects treatment in tissue engineering due to their versatile attributes.
机译:在本研究中,通过溶胶 - 凝胶法合成了具有和不含表面活性剂(非离子嵌段共聚物,E020PO30020P123)的68SiO(2)-23CaO-4P(2)O(5)-Cuo生物发作(非离子嵌段共聚物,E020PO30020P123)。所得干燥的溶胶在40℃下进行蒸发诱导的自组装(EISA)方法,完成TG-DTA(热重分析热分析)以获得用于煅烧制备的粉末的优化温度。将干燥的凝胶在650℃下煅烧2小时,得到最终的生物制剂。然后,通过傅里叶变换红外光谱(FTIR),X射线衍射(XRD),扫描电子显微镜(SEM),透射电子显微镜(SEM),透射电子显微镜(TEM),透射电子显微镜(TEM),扫描电子显微镜(TEM),扫描电子显微镜(TEM),扫描电子显微镜(TEM),扫描电子显微镜(TEM),扫描电子显微镜(TEM), - Emmett-Teller(Bet)分析。此外,检查了粉末的生物学行为(生物活性,生物相容性和抗菌性质),用于其在医学科学的适用性。结果表明,合成的生物胶粉形成了介于纳米大小形态和高表面积的中孔结构,以及合适的生物学特性。 P123(非离子嵌段共聚物E020PO702020)表面活性剂负责改善模板生物制剂的均匀间孔结构和生物学特征。此外,在玻璃结构中使用铜的使用不抑制其抗细菌性质,并导致风险低风险的生物胶。最后,由于其多功能属性,这种合成的生物活性玻璃可以具有骨缺陷治疗的潜在能力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号